Howorth support GSK in the development of COVID-19 adjuvant vaccines.
GSK has confirmed its intention to manufacture one billion doses of pandemic vaccine adjuvant in 2021 to support the development of multiple COVID-19 vaccine collaborations.
GSK has confirmed its intention to manufacture one billion doses of pandemic vaccine adjuvant in 2021 to support the development of multiple COVID-19 vaccine collaborations.
ConstructSecure, Inc., a cloud-based mobile platform that empowers clients to make smarter risk management decisions, has announced the recipients of its prestigious safety awards.
Howorth are delighted to have signed a partnership agreement with Medical S.p.A in Italy. Founded in 1977, the company has gained experience and expertise over the years in the healthcare field through the import and distribution of innovative products for public and private facilities.Â
We are looking forward to attending the virtual Manufacturing Chemist Live and Cleanroom Technology Conference 2020 on the 10th & 11th November.
We’re getting ready to support our partner, Solid Pharma, at the Pharmtech & Ingredients International exhibition 2020 in Moscow, which takes place between 10th-13th November.
Howorth are delighted to have signed a partnership agreement with Solid Pharma in Russia, further strengthening our global representation in the supply of Pharmaceutical containment equipment.